OQROGet OQRO Pro
Insider trade

Becton Dickinson (BDX)Director sold ~$38K

Bertram L Scott, Director at Becton Dickinson, sold ~$38K of Becton Dickinson shares.

~$38K
Approx. value · 217 sh @ $176.58
36K
Holds after · shares reported
Traded
Nov 7, 2025
Filed
Nov 7, 2025

The story around this disclosure

Every dated public record OQRO holds about the company from 60 days before to 120 days after, oldest first. It shows what was going on; none of it is a stated reason for the trade.

  1. Sep 10, 2025InsiderDirector sold ~$172K of BDX shares in the open market
  2. Sep 16, 2025Company filing · Form 8-K · Material agreement, New debtSigned an important agreement, and took on new debt or obligations
  3. Sep 26, 2025InsiderOfficer sold ~$10K of BDX shares in the open market
  4. Oct 9, 2025Company filing · Form 8-K · Results, Executive changeChanged a top executive or board member, and reported its results (and 1 more item)“On October 9, 2025, Christopher J. DelOrefice informed Becton, Dickinson and Company (the “Company” or “BD”) of his intention to resign from his position as the Company’s Executive Vice President and Chief Financial Officer effective December 5, 2025 to pursue a new professional opportunity.”
  5. Oct 27, 2025InsiderOfficer sold ~$11K of BDX shares in the open market
  6. Oct 31, 2025Layoff notice · 3750 Torrey View Court San Diego CA 92130Layoff notice filed in CA: 59 employees
  7. Oct 31, 2025Layoff notice · 10020 Pacific Mesa Boulevard San Diego CA 92121Layoff notice filed in CA: 7 employees
  8. Nov 6, 2025Company filing · Form 8-K · ResultsReported its results
  9. Nov 6, 2025FDARecall: BD InLay Optima Ureteral Stent Kit Size: 6 Fr. x 30 cm, Ureteral Stent Kit REF 788630
  10. Nov 6, 2025FDARecall: Bard InLay Optima Size: 6 Fr. x 14 cm, Ureteral Stent Kit REF 787614
  11. Nov 6, 2025FDARecall: BD InLay Optima Ureteral Stent Kit Size: 4.7 Fr. x 26 cm, Ureteral Stent Kit REF 788426
  12. Nov 6, 2025FDARecall: Safe-T-Centesis 6 Fr Catheter Drainage Tray, REF: PIG1260T,
  13. Nov 7, 2025 · this disclosureInsiderDirector sold ~$38K of BDX shares in the open market

What came next

  1. Nov 17, 2025Company filing · Form 8-K · Executive changeChanged a top executive or board member“On November 17, 2025, Robert L. Huffines and Jacqueline Wright were elected to the Board of Directors (the “Board”) of Becton, Dickinson and Company (“BD”), effective December 1, 2025.”
  2. Nov 17, 2025Company filing · Form 8-K · Executive changeChanged a top executive or board member“DEPARTURE OF DIRECTORS OR PRINCIPAL OFFICERS; ELECTION OF DIRECTORS; APPOINTMENT OF PRINCIPAL OFFICERS. In connection with their appointments to the Board, effective December 1, 2025, Mr. Huffines and Ms. Wright will each receive restricted stock units valued at $33,575, representing a prorated grant from the effective date of their election to the Board through BD’s 2026 Annual Meeting of Shareholders.”
  3. Nov 20, 2025FDARecall: BD Pyxis MedStation ES, REF: 323, BD Pyxis MedStation ES 7 Drawer Auxiliary, REF: 324, BD Pyxis MedStation ES Tower, REF: 352, BD Pyxis Pro 7-Drawer Auxiliary,…
  4. Dec 1, 2025InsiderOfficer sold ~$15K of BDX shares in the open market
  5. Dec 2, 2025FDAFDA device clearance: 0.9 % Sodium Chloride Injection, USP, BD PosiFlush™ SP Syringe
  6. Dec 3, 2025FDARecall: BD Pyxis ES Enterprise Server Catalog Numbers 1115-00, 137672-02,137672-03 137671-02, 137671-03, 137670-02, 137670-03, 139676-01, 139421-01, 139420-01, 139419-…
  7. Dec 12, 2025FDAFDA device clearance: EnCor EnCompass™ Breast Biopsy and Tissue Removal System
  8. Dec 12, 2025FDARecall: Broviac 4.2 Fr Single-Lumen CV Catheter Cutdown Tray with SureCuff Tissue Ingrowth Cuff Cat 60060
  9. Dec 17, 2025FDARecall: BD ChloraPrep" Triple Swabsticks (Chlorhexidine gluconate (CHG), 2% w/v and Isopropyl alcohol (IPA), 70% v/v), 5.25 mL Applicator, CareFusion 213, LLC, El Paso…
  10. Dec 17, 2025InsiderOfficer sold ~$123K of BDX shares in the open market
  11. Dec 26, 2025InsiderOfficer sold ~$15K of BDX shares in the open market
  12. Dec 30, 2025Company filing · Form 8-K · Temporary Suspension of Trading Under Registrant's Employee Benefit PlansSuspended trading under its employee plans
  13. Jan 15, 2026Insider · 1 personInsiders: 2 sales (~$334K)
  14. Jan 26, 2026InsiderOfficer sold ~$15K of BDX shares in the open market
  15. Jan 27, 2026Company filing · Form 8-K · Executive change, Shareholder voteChanged a top executive or board member, and held a shareholder vote“On January 27, 2026, the Board of Directors of Becton, Dickinson and Company (“BD”) approved and adopted the BD Executive Severance Plan (the “Severance Plan”), effective January 27, 2026.”
  16. Jan 27, 2026FDARecall: 10mL Non-Sterile BD Luer-Lok Tip Syringe Only. Catalog Number: 301029. 850 bulk non-sterile units per case.
  17. Jan 30, 2026Company filing · Form 8-K · Unregistered shares, Bylaws or charterSold new shares without registering them, and changed its bylaws, charter or fiscal year
  18. Jan 30, 20265% stakeThe Vanguard Group reported a passive stake (13G) of 12.8%
  19. Feb 4, 2026FDAFDA device clearance: UltraScore™ Focused Force PTA Balloon
  20. Feb 9, 2026Company filing · Form 8-K · ResultsReported its results
View the official recordSEC Form 4

How to read SEC Form 4

Form 4 is the filing that officers, directors and owners of more than 10% of a US-listed company must send to the SEC within two business days after they buy, sell or otherwise change their holding of the company's stock.

Full guide: What is an SEC Form 4?

What else is on file for Becton Dickinson

For Becton Dickinson, OQRO holds 6 insider filings (SEC Form 4 or Form 144), 1 Congress trade report and 28 fund holdings reports (13F) dated in the last 90 days.

These are records OQRO holds, counted by their date, not a measure of how much trading took place. Routine paperwork such as option exercises and tax withholding is left out. Everything for the company is on its BDX page.

Other recent filings by Bertram L Scott, Director

The full history of Bertram L Scott, Director is on the profile page.

How this filing works

Other disclosures at Becton Dickinson

Everything OQRO holds on this company is on its BDX page.

This is one filing. OQRO holds the rest

Insider trades filed with the SEC, stock trades disclosed by members of Congress, fund holdings from 13F filings and federal contract awards, each one in plain words next to its official filing. On this page it opens why the trade stands out, what the company did around that time, the price since, and every field of the form.

Unlock OQRO ProAlready have an account? Log in

OQRO Pro is a paid subscription. You see the price before you pay

OQRO describes public disclosures and context calculated from them. It does not give personalized advice and does not recommend any transaction. How OQRO treats data